Hanmi Pharmaceutical is leading innovation in the pharmaceutical industry with a sustainable R&D infrastructure covering various therapeutic areas. They have a pipeline of 28 new drugs, including 8 drugs for metabolic diseases, 12 anti-cancer drugs, 5 drugs for rare diseases, and 3 drugs for other diseases.
